Major shareholder announcement

Novozymes hereby announces that Baillie Gifford & Co, together with its wholly owned subsidiary Baillie Gifford Overseas Limited, now holds 5.04% of the B shares in Novozymes

In accordance with section 29 of the Danish Securities Trading Act, Novozymes hereby announces that it has been informed that Baillie Gifford & Co, together with its wholly owned subsidiary Baillie Gifford Overseas Limited, now holds 5.04% of the B shares in Novozymes, previously reported at 4.99% in company announcement no. 14, March 2016.
 
Baillie Gifford & Co, together with its wholly owned subsidiary Baillie Gifford Overseas Limited, now holds B shares in Novozymes A/S to a total of 15,639,344 shares of a nominal value of DKK 31,278,688, equivalent to 5.04% of Novozymes A/S’ share capital and 1.97% of the voting rights.

pdf16 Read the full announcement in pdf